09 January 2025 | Thursday | News
Picture Courtesy | Public Domain
InkSpace Imaging, a leader in MRI coil innovation, announced that the United States (US) Food and Drug Administration (FDA) has cleared InkSpace Imaging’s next-generation 1.5 Tesla (1.5T) 24-channel MR coil for Siemens Healthineers Magnetom MRI scanners. This new medical device is part of their industry-leading suite of MR coils designed to revolutionize the patient experience while enhancing efficiency in MRI scans and clinical diagnosis.
Designed for efficiency and precision, the 1.5T MR coil leverages InkSpace Imaging’s proprietary coil technology to deliver superior image quality. This enhances diagnostic confidence while streamlining radiology workflows. The coil’s lightweight and flexible design improves patient comfort and clinical performance.
A Major Milestone in MRI Technology
“This FDA 510(k) clearance is a testament to our commitment to innovation and excellence in next-generation MRI coil development and adds to our growing portfolio of high-performance and super lightweight solutions at 1.5T and 3T,” said Dr. Peter Fischer, CEO of InkSpace Imaging. “The 1.5T MR coil sets a new benchmark for image quality and operational efficiency, empowering radiologists to achieve better patient outcomes.”
Benefits of the 1.5T 24-Channel MR coil
Efficiency Meets Precision
Several advancements in coil technology drive the 1.5T MR coil’s enhanced image quality.
© 2025 Biopharma Boardroom. All Rights Reserved.